LANTERN PHARMA INC. (LTRN) Operating cash flow 2019–2025
LANTERN PHARMA INC. (LTRN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.7MFY2025 · since FY2019: -$2.1M → -$15.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.7M | +12.0% |
| FY2024 | -$17.8M | -24.2% |
| FY2023 | -$14.3M | -12.4% |
| FY2022 | -$12.8M | -20.5% |
| FY2021 | -$10.6M | -87.4% |
| FY2020 | -$5.7M | -165.6% |
| FY2019 | -$2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LTRN financial trends
LTRN RevenueLTRN Net incomeLTRN Net marginLTRN Gross profitLTRN Gross marginLTRN Operating incomeLTRN Operating marginLTRN Free cash flowLTRN Capital expendituresLTRN Return on equityLTRN Stock buybacksLTRN Dividends paidLTRN Total assetsLTRN Total liabilitiesLTRN Shareholders’ equityLTRN overview →